Current landscape of preoperative neoadjuvant therapies for initial resectable colorectal cancer liver metastasis

doi:10.3748/wjg.v30.i7.663

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (992)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

648

Figures (1-1)

Tables (1-1)

Sum=821

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=119

Feb 21, 2024 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Feb 21, 2024; 30(7): 663-672
Published online Feb 21, 2024. doi: 10.3748/wjg.v30.i7.663

Open in New Tab Full Size Figure Download Figure

Figure 1 Key Considerations for the paradigm of neoadjuvant or direct surgery in resectable colorectal cancer liver metastasis. The figure outlines factors such as surgical standards, technical considerations, tumor characteristics, prognostic factors, and key markers influencing treatment decisions. MDT: Multidisciplinary team; CRS: Clinical risk score; CEA: Carcinoembryonic antigen; MMR: Mismatch repair; ctDNA: Circulating tumor DNA.

Citation: Cheng XF, Zhao F, Chen D, Liu FL. Current landscape of preoperative neoadjuvant therapies for initial resectable colorectal cancer liver metastasis. World J Gastroenterol 2024; 30(7): 663-672
URL: https://www.wjgnet.com/1007-9327/full/v30/i7/663.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i7.663